Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Majd B Aboona1, Pojsakorn Danpanichkul2,3, Vincent L Chen4
1University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
Background And Aim:
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a leading cause of chronic liver disease worldwide. A new entity termed MetALD has also been described and is defined as individuals with MASLD and increased alcohol intake. However, the natural history of MetALD compared with MASLD is unknown. We aimed to compare longitudinal outcomes in patients with MASLD versus MetALD.
Methods:
This study was performed using data from the National Health and Nutrition Examination Survey from 2011 to 2018. MASLD patients (defined by the United States Fatty Liver Index > 30) who met cardiometabolic criteria including body mass index (BMI) > 25 (BMI > 23 in Asians), hypertension, diabetes mellitus, dyslipidemia, and hypertriglyceridemia were included. MetALD was defined as MASLD with increased alcohol intake (3-6 standard drinks per day in males; 2-5 standard drinks per day in females). A comparison of overall, cardiovascular, cancer-related, and other causes of mortality in patients with MASLD versus MetALD was performed.
Results:
A total of 2838 individuals with MASLD and 2557 individuals with MetALD were included with a median follow-up time of 56 months. MetALD patients were at increased risk of cancer-related mortality compared with patients with MASLD (hazard ratio 1.32; 95% confidence interval 1.14-1.53; P < 0.01). However, there was no significant difference in overall, cardiovascular, and other causes of mortality.
Conclusions:
Patients with MetALD were at higher risk for cancer-related mortality than MASLD. Close attention to regular cancer surveillance and accurate classification of alcohol consumption in individuals with diagnosed MASLD is warranted to help improve patient care and outcome.
Insights
Metabolic dysfunction-associated steatotic liver disease (MASLD) patients with increased alcohol intake (MetALD) face a higher risk of cancer mortality compared to MASLD alone. Accurate alcohol assessment is crucial for managing MASLD and MetALD patients.
Area of Science:
- Hepatology
- Internal Medicine
- Public Health
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern.
- Metabolic dysfunction-associated steatotic liver disease with alcohol intake (MetALD) is a newly described entity.
- The comparative natural history of MetALD and MASLD remains largely unknown.
Purpose of the Study:
- To compare the longitudinal health outcomes of patients with MASLD versus MetALD.
- To investigate differences in overall, cardiovascular, cancer-related, and other mortality causes between MASLD and MetALD cohorts.
Main Methods:
- Utilized data from the National Health and Nutrition Examination Survey (2011-2018).
- Defined MASLD using the United States Fatty Liver Index (>30) and cardiometabolic criteria.
- Defined MetALD as MASLD with specific daily alcohol intake thresholds for males and females.
Main Results:
- Included 2838 MASLD and 2557 MetALD patients with a median follow-up of 56 months.
- MetALD patients exhibited a significantly increased risk of cancer-related mortality (HR 1.32; P < 0.01).
- No significant differences were observed in overall, cardiovascular, or other causes of mortality between the groups.
Conclusions:
- MetALD patients demonstrate a higher risk for cancer-related mortality compared to MASLD patients.
- Emphasizes the need for vigilant cancer surveillance in MASLD patients.
- Highlights the importance of accurately classifying alcohol consumption for improved patient outcomes.
More Related Videos
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
CNS Depressants: Alcohol and Nicotine
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

